Patent ID: 11952409
Assignee: IMMATICS BIOTECHNOLOGIES GMBH
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A method of treating a patient who has cancer, comprising administering to said patient a population of activated T cells that kill cancer cells that present a peptide consisting of the amino acid sequence of IYLDRTLLTTI (SEQ ID NO: 56), wherein the cancer is non-small cell lung cancer adenocarcinoma (NSCLCadeno), squamous cell non-small cell lung cancer (NSCLCsquam), head and neck squamous cell carcinoma (HNSCC), gallbladder cancer (GBC), renal cell carcinoma (RCC), NSCLC samples that could not unambiguously be assigned to NSCLCadeno or NSCLCsquam (NSCLCother), esophageal cancer (OSCAR), gastric cancer (GC), uterine endometrial cancer (UEC), small cell lung cancer (SCLC), melanoma (MEL), hepatocellular carcinoma (HCC), and cholangiocellular carcinoma (CCC).